Skip to main content

Table 3 PET/CT outcome and CRC recurrence in CEA subgroups

From: Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA

 

CEA subgroups

1 increase (n = 30)

2 increases (n = 26)

>2 increases (n = 5)

Persistently elevated (n = 12)

Number of PET/CT-positive patients

19 (63 %)

7 (27 %)

3 (60 %)

3 (25 %)

Number of patients with CRC recurrence

18 (60 %)

10 (38 %)

3 (60 %)

4 (33 %)

Median CEA, μg/L

6.75

4.85

4.0

5.7

CEA range, μg/L

1.7–164.0

2.3–16.4

1.5–6.1

3.4–7.8

  1. PET/CT positron emission tomography/computed tomography, CRC colorectal cancer, CEA carcinoembryonic antigen